Improving Gout Care After an ED Visit
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- University of Alabama at Birmingham
- Study ID
- NCT06534554
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 99 Years
- Healthy Volunteers
- Not accepted
Interventions
- Patient Navigation — BEHAVIORALA lay patient navigator working will contact patients seen in the UAB ED via phone within \~72 hours following the ED visit. During this initial phone conversation, the navigators will: 1) conduct a baseline assessment to identify barriers to attending an outpatient visit for gout care and to adhering to gout treatment recommendations and 2) determine the level of support and assistance needed by the patient.
Study Details
The prevalence of gout has been steadily increasing over several decades and is correlated with the rising burden of obesity, chronic cardiac and renal disease; all conditions overrepresented in the Southeastern U.S. - particularly in African Americans. Through a novel post-emergency department visit intervention, we aim to improve the care patients with gout receive, both during acute exacerbations and long-term. A secondary goal of the project is to concurrently enhance participation of minorities in biomedical research in the Deep South.
Key Dates
- Start date
- Jun 18, 2024
- Status verified
- Jan 2026
- Primary completion
- Jan 1, 2027
- Completion
- Jun 1, 2027
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Patient NavigationA lay patient navigator will contact patients seen in the UAB ED via phone within \~72 hours following the ED visit. During this initial phone conversation, the navigators will: 1) conduct a baseline assessment to identify barriers to attending an outpatient visit for gout care and to adhering to gout treatment recommendations and 2) determine the level of support and assistance needed by the patient.
- No Intervention: ControlUsual Care
Primary Outcome Measure
Follow-Up Visit Addressing Gout within 3 Months [ Time Frame: 3 months ]
Central Contacts
- Lesley E. Jackson, MD(812) 322-0637
- Zac Armor(205) 934-1779
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35205 | Kenneth G. Saag, MD (PRINCIPAL_INVESTIGATOR) Lesley E. Jackson, MD (SUB_INVESTIGATOR) |
Find similar trials in Birmingham, AL
By research site
Related Studies
- Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in GoutPHASE4 · Recruiting · Massachusetts General Hospital · South Birmingham, Alabama
- Study of Dapansutrile Tablets in Subjects With an Acute Gout FlarePHASE2/PHASE3 · Recruiting · Olatec Therapeutics LLC · Birmingham, Alabama
- A Study of Dotinurad Versus Allopurinol in Participants With GoutPHASE3 · Recruiting · Crystalys Therapeutics · Birmingham, Alabama
- Dose Response of Exercise for Arthritis ManagementRecruiting · University of South Carolina · Columbia, South Carolina